Used as a key intermediate in the synthesis of fluorinated pharmaceutical compounds, particularly in the development of sulfonamide-based drugs with enhanced metabolic stability and bioavailability. Its structure supports the design of potent enzyme inhibitors, especially in oncology and anti-inflammatory agents, where fluorine substitution improves target binding and pharmacokinetic properties. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its rigid aromatic framework and halogen positioning.